NAM
TXG icon

NorthCoast Asset Management’s 10x Genomics TXG Stock Holding History

NorthCoast Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$568K Hold
3,900
– – 0.02% 331
2021
Q2 		$764K Sell
3,900
-800
-17% -$145K 0.03% 296
2021
Q1 		$851K Buy
4,700
+100
+2% +$17.3K 0.03% 252
2020
Q4 		$651K Buy
+4,600
New +$668K 0.03% 240

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NorthCoast Asset Management's TXG Position: Q3 2021 in Review

NorthCoast Asset Management held its 10x Genomics (TXG) position steady in Q3 2021 at 3,900 shares worth $568K. The position accounts for 0.02% of the portfolio, ranked #331.

NorthCoast Asset Management first reported a position in TXG in Q4 2020 and has held it in 4 quarters since. The position peaked at $851K in Q1 2021. 330 funds tracked by Wall St. Rank hold TXG as of Q3 2021.

  • NorthCoast Asset Management held 3,900 shares of 10x Genomics worth $568K as of Q3 2021.
  • NorthCoast Asset Management left its 10x Genomics share count unchanged in Q3 2021.
  • 10x Genomics made up 0.02% of NorthCoast Asset Management's portfolio in Q3 2021, its #331 holding.
  • NorthCoast Asset Management first reported a position in 10x Genomics in Q4 2020 and has held it in 4 quarters since.
  • NorthCoast Asset Management's 10x Genomics position peaked at $851K in Q1 2021.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.